PeptideDB

Prussian blue insoluble

CAS: 14038-43-8 F: C18Fe7N18 W: 859.23

Prussian blue insoluble (Iron(III) ferrocyanide) is a good adsorbent to be used as antidotes for poisoning with cesium o
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity Prussian blue insoluble (Iron(III) ferrocyanide) is a good adsorbent to be used as antidotes for poisoning with cesium or thallium ions. Prussian blue insoluble (Iron(III) ferrocyanide) has anticancerous and antibacterial properties. Prussian blue insoluble (Iron(III) ferrocyanide) can be used as a contrast agent in photoacoustic and magnetic resonance imaging (MRI). Prussian blue insoluble can be used for contrast agents, antidotes and cancer research[1][2][3][4].
Invitro Prussian blue insoluble (Iron(III) ferrocyanide) (0.1-3.0μg/mL; 24 hours; HUVECs) has photo-thermal effect and inhibits cell viabilities[1]. Prussian blue insoluble (Iron(III) ferrocyanide) (0.07 mM; 0-24 hours) act as a metabolic indicator, being reduced by bacterial metabolism, producing a visible color change from blue to colorless[2]. Cell Viability Assay[1] Cell Line:
In Vivo Prussian blue insoluble (3 g/day; p.o.; for 8 days; rats)(Iron(III) ferrocyanide) can be used as a therapeutic agent in radiocesium and thallium poisoning[3]. Animal Model:
Name Prussian blue insoluble
CAS 14038-43-8
Formula C18Fe7N18
Molar Mass 859.23
Appearance Solid
Transport Room temperature in continental US; may vary elsewhere.
Storage
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
Reference [1]. Chen HJ, et, al. Facile synthesis of Prussian blue nanoparticles as pH-responsive drug carriers for combined photothermal-chemo treatment of cancer. RCS advances. 2016 Oct 9; 7:248-255. [2]. Ferrer-Vilanova A, et, al. Electrochromogenic Detection of Live Bacteria Using Soluble and Insoluble Prussian Blue. ACS Omega. 2021 Nov 11;6(46):30989-30997. [3]. Thompson DF, et, al. Soluble or insoluble prussian blue for radiocesium and thallium poisoning? Ann Pharmacother. 2004 Sep;38(9):1509-14. [4]. Busquets MA, et, al. Prussian blue nanoparticles: synthesis, surface modification, and biomedical applications. Drug Discov Today. 2020 Aug;25(8):1431-1443.